GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial

被引:71
作者
Goegebakan, Oezlem [1 ,2 ]
Osterhoff, Martin A. [1 ,2 ]
Schueler, Rita [1 ]
Pivovarova, Olga [1 ,2 ]
Kruse, Michael [1 ]
Seltmann, Anne-Cathrin [1 ]
Mosig, Alexander S. [3 ]
Rudovich, Natalia [1 ,2 ]
Nauck, Michael [4 ]
Pfeiffer, Andreas F. H. [1 ,2 ]
机构
[1] Potsdam Rehbruecke, Dept Clin Nutr, German Inst Human Nutr, D-14558 Nuthetal, Germany
[2] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany
[3] Jena Univ Hosp, Res Grp Mol Hemostaseol, Jena, Germany
[4] Diabet Zentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany
关键词
Adipose tissue; GIP; Inflammation; MCP-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; GASTRIC-INHIBITORY POLYPEPTIDE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; DIABETES-MELLITUS; OBESITY; RESISTANCE; GLUCOSE; ADIPOCYTES; FAT;
D O I
10.1007/s00125-015-3618-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Obesity is associated with elevated monocyte chemoattractant protein-1 (MCP-1), a proinflammatory chemokine related to diabetes and cardiovascular disease. Since obesity is triggered by energy dense diets, we hypothesised that nutrient induced intestinal hormones such as glucose-dependent insulinotropic peptide (GIP) may directly stimulate the release of chemokines from adipose tissue and induce low-grade inflammation. Methods GIP effects on gene expression and secretion of inflammatory markers were studied by microarray analysis and PCR from human subcutaneous fat biopsies of slightly obese but healthy volunteers in the metabolic ward of German Institute of Human Nutrition, Department of Clinical Nutrition, Potsdam-Rehbrucke. To allocate the participants to the study arms they were numbered in order of their recruitment and then assigned to the groups by a random number generator. In a randomised, single-blind (participants) crossover design, the participants received GIP infusions in postprandial concentrations (2 pmol kg(-1) min(-1)) or saline (154 mmol/l NaCl) infusions for 240 min either alone, in combination with hyperinsulinaemic-euglycaemic (EU) or hyperinsulinaemic-hyperglycaemic (HC) clamps. Possible mechanisms of GIP effects were investigated in single and co-cultures of macrophage and adipocyte cell lines and in primary human monocytes, macrophages and adipocytes. Results A total of 17 participants were randomised to the following groups: EU with GIP infusion (n=9) EU with NaCl infusion (n=9) HC with GIP infusion (n=8); HC with NaCl infusion (n=8) sole GIP infusion (n=11) and sole placebo infusion (n=11). All 17 individuals were analysed. The study is completed. In human subcutaneous adipose tissue (hSCAT), infusions of GIP significantly increased inflammatory chemokine and cytokine gene networks in transcriptomic microarray analyses. Particularly MCP-1 (180 +/- 26%), MCP-2 (246 +/- 58%) and IL-6 (234 +/- 40%) mRNA levels in adipose tissue as well as circulating plasma concentrations of MCP-1 (165 +/- 12 vs 135 +/- 13 pg/ml; GIP vs saline after 240 min; p<0.05 for all variables) in humans increased independently of circulating insulin or glucose plasma concentrations. GIP stimulation increased Mcp-1 mRNA-expression in co-cultures of differentiated 3T3L1-adipocytes and RAW 264.7 macrophages but not in the isolated cell lines. Similarly, GIP increased MCP-1 transcripts in co-cultures of primary human macrophages with human adipocytes. GIP receptor (GIPR) transcripts were present in primary monocytes and the different cell lines and induced activation of extracellular related kinase (ERK) as well as increases in cAMP, indicating functional receptors. Conclusions/interpretation Our findings suggest that the nutrient induced gut hormone GIP may initiate adipose tissue inflammation by triggering a crosstalk of adipocytes and macrophages involving MCP-1.
引用
收藏
页码:1759 / 1768
页数:10
相关论文
共 37 条
  • [1] IKK-β links inflammation to obesity-induced insulin resistance
    Arkan, MC
    Hevener, AL
    Greten, FR
    Maeda, S
    Li, ZW
    Long, JM
    Wynshaw-Boris, A
    Poli, G
    Olefsky, J
    Karin, M
    [J]. NATURE MEDICINE, 2005, 11 (02) : 191 - 198
  • [2] Biology of incretins: GLP-1 and GIP
    Baggio, Laurie L.
    Drucker, Daniel J.
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2131 - 2157
  • [3] Iterative Group Analysis (iGA): A simple tool to enhance sensitivity and facilitate interpretation of microarray experiments
    Breitling, R
    Amtmann, A
    Herzyk, P
    [J]. BMC BIOINFORMATICS, 2004, 5 (1)
  • [4] Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway
    Ehses, JA
    Pelech, SL
    Pederson, RA
    McIntosh, CHS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) : 37088 - 37097
  • [5] GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE SECRETION IN RESPONSE TO NUTRIENT INGESTION IN MAN - ACUTE POSTPRANDIAL AND 24-H SECRETION PATTERNS
    ELLIOTT, RM
    MORGAN, LM
    TREDGER, JA
    DEACON, S
    WRIGHT, J
    MARKS, V
    [J]. JOURNAL OF ENDOCRINOLOGY, 1993, 138 (01) : 159 - 166
  • [6] Innate immunity, insulin resistance and type 2 diabetes
    Fernandez-Real, Jose Manuel
    Pickup, John C.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (01) : 10 - 16
  • [7] Dorothy Hodgkin Lecture 2008 Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes?
    Flatt, P. R.
    [J]. DIABETIC MEDICINE, 2008, 25 (07) : 759 - 764
  • [8] Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes
    Gault, VA
    Irwin, N
    Green, BD
    McCluskey, JT
    Greer, B
    Bailey, CJ
    Harriott, P
    O'Harte, FPM
    Flatt, PR
    [J]. DIABETES, 2005, 54 (08) : 2436 - 2446
  • [9] Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
    Hansotia, Tanya
    Maida, Adriano
    Flock, Grace
    Yamada, Yuichiro
    Tsukiyama, Katsushi
    Seino, Yutaka
    Drucker, Daniel. J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (01) : 143 - 152
  • [10] EFFECTS OF GASTRIC-INHIBITORY POLYPEPTIDE ON GLUCOSE AND LIPID-METABOLISM OF ISOLATED RAT ADIPOCYTES
    HAUNER, H
    GLATTING, G
    KAMINSKA, D
    PFEIFFER, EF
    [J]. ANNALS OF NUTRITION AND METABOLISM, 1988, 32 (5-6) : 282 - 288